156 related articles for article (PubMed ID: 37588207)
1. A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis.
Bi Y; Zheng R; Hu J; Shi R; Shi J; Wang Y; Wang P; Jiang W; Kim G; Liu Z; Li X; Lin L
Genes Dis; 2024 Jan; 11(1):479-494. PubMed ID: 37588207
[TBL] [Abstract][Full Text] [Related]
2. Corrigendum to "A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis" [Genes & Diseases 11 (2024) 479-494].
Bi Y; Zheng R; Hu J; Shi R; Shi J; Wang Y; Wang P; Jiang W; Kim G; Liu Z; Li X; Lin L
Genes Dis; 2024 May; 11(3):101168. PubMed ID: 38292171
[TBL] [Abstract][Full Text] [Related]
3. FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.
Wang K; Ji W; Yu Y; Li Z; Niu X; Xia W; Lu S
Oncogene; 2018 Sep; 37(39):5340-5354. PubMed ID: 29858603
[TBL] [Abstract][Full Text] [Related]
4. The FGFR1 inhibitor PD173074 induces mesenchymal-epithelial transition through the transcription factor AP-1.
Nguyen PT; Tsunematsu T; Yanagisawa S; Kudo Y; Miyauchi M; Kamata N; Takata T
Br J Cancer; 2013 Oct; 109(8):2248-58. PubMed ID: 24045665
[TBL] [Abstract][Full Text] [Related]
5. Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.
Li Z; Chen Y; An T; Liu P; Zhu J; Yang H; Zhang W; Dong T; Jiang J; Zhang Y; Jiang M; Yang X
J Exp Clin Cancer Res; 2019 Mar; 38(1):139. PubMed ID: 30922391
[TBL] [Abstract][Full Text] [Related]
6. Echinacoside (ECH) suppresses proliferation, migration, and invasion of human glioblastoma cells by inhibiting Skp2-triggered epithelial-mesenchymal transition (EMT).
Shi S; Qin Y; Chen D; Deng Y; Yin J; Liu S; Yu H; Huang H; Chen C; Wu Y; Zou D; Wang Z
Eur J Pharmacol; 2022 Oct; 932():175176. PubMed ID: 35995211
[TBL] [Abstract][Full Text] [Related]
7. HMGB1-Induced p62 Overexpression Promotes Snail-Mediated Epithelial-Mesenchymal Transition in Glioblastoma Cells via the Degradation of GSK-3β.
Li H; Li J; Zhang G; Da Q; Chen L; Yu S; Zhou Q; Weng Z; Xin Z; Shi L; Ma L; Huang A; Qi S; Lu Y
Theranostics; 2019; 9(7):1909-1922. PubMed ID: 31037147
[No Abstract] [Full Text] [Related]
8. The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT.
Ryan MR; Sohl CD; Luo B; Anderson KS
Mol Cancer Res; 2019 Feb; 17(2):532-543. PubMed ID: 30257990
[TBL] [Abstract][Full Text] [Related]
9. FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).
Jiao J; Zhao X; Liang Y; Tang D; Pan C
Biochem Biophys Res Commun; 2015 Oct; 466(3):327-32. PubMed ID: 26362179
[TBL] [Abstract][Full Text] [Related]
10. Integrin α3 Mediates Stemness and Invasion of Glioblastoma by Regulating POU3F2.
Yao J; Wang L
Curr Protein Pept Sci; 2023; 24(3):247-256. PubMed ID: 36843258
[TBL] [Abstract][Full Text] [Related]
11. CCL2-targeted ginkgolic acid exerts anti-glioblastoma effects by inhibiting the JAK3-STAT1/PI3K-AKT signaling pathway.
Chen X; Zhu M; Zou X; Mao Y; Niu J; Jiang J; Dong T; Shi Y; Yang X; Liu P
Life Sci; 2022 Dec; 311(Pt B):121174. PubMed ID: 36396110
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of novel pyrimidinylaminothiophene derivatives as FGFR1 inhibitors against human glioblastoma multiforme.
Li YL; Yan LJ; Chen HX; Ruan BK; Dao P; Du ZY; Dong CZ; Meunier B
Eur J Med Chem; 2023 Nov; 260():115764. PubMed ID: 37651879
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-Specific Protease 3 Promotes Glioblastoma Cell Invasion and Epithelial-Mesenchymal Transition via Stabilizing Snail.
Fan L; Chen Z; Wu X; Cai X; Feng S; Lu J; Wang H; Liu N
Mol Cancer Res; 2019 Oct; 17(10):1975-1984. PubMed ID: 31266817
[TBL] [Abstract][Full Text] [Related]
14. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
[TBL] [Abstract][Full Text] [Related]
15. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
[TBL] [Abstract][Full Text] [Related]
16. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
[TBL] [Abstract][Full Text] [Related]
17. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.
Feng S; Shao L; Castro P; Coleman I; Nelson PS; Smith PD; Davies BR; Ittmann M
Oncotarget; 2017 Jan; 8(4):6179-6192. PubMed ID: 28008155
[TBL] [Abstract][Full Text] [Related]
18. Spatial distribution and functional relevance of FGFR1 and FGFR2 expression for glioblastoma tumor invasion.
Alshahrany N; Begum A; Siebzehnrubl D; Jimenez-Pascual A; Siebzehnrubl FA
Cancer Lett; 2023 Sep; 571():216349. PubMed ID: 37579831
[TBL] [Abstract][Full Text] [Related]
19. Verbascoside suppresses the migration and invasion of human glioblastoma cells via targeting c-Met-mediated epithelial-mesenchymal transition.
Hei B; Wang J; Wu G; Ouyang J; Liu RE
Biochem Biophys Res Commun; 2019 Jul; 514(4):1270-1277. PubMed ID: 31113618
[TBL] [Abstract][Full Text] [Related]
20. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
